Recruitment of black women for a study of inherited breast cancer using a cancer registry-based approach

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 1-2, 2011, Pages 69-77

  Pal, Tuya ^a,b   Rocchio, Erin ^a   Garcia, Ana ^a   Rivers, Desiree ^a   Vadaparampil, Susan ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER REGISTRY; CANCER RISK; CANCER STAGING; FAMILIAL CANCER; FOLLOW UP; GENE MUTATION; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; RACE DIFFERENCE;

AFRICAN AMERICANS; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PERSONNEL SELECTION; REGISTRIES; WOMEN;

EID: 79951965174     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0098     Document Type: Article

References (65)

1. Anderson CA, Beresford SA, Lampe J, et al. (2007) Enhancing recruitment of healthy African American volunteers in a city with a small African American community: results from a dietary supplement crossover trial. Ethn Dis 17:555-559. (Pubitemid 47606767)
2. Antoniou A, Pharoah PD, Narod S, et al. (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117-1130. (Pubitemid 36530000)
3. Armstrong K, Micco E, Carney A, et al. (2005) Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 293:1729-1736.
4. Aziz H, Hussain F, Sohn C, et al. (1999) Early onset of breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol 22:436-440. (Pubitemid 30263286)
5. Bennett JC (1993) Inclusion of women in clinical trials - policies for population subgroups. N Engl J Med 329:288-292.
6. Beskow LM, Sandler RS, Millikan RC, Weinberger M (2005) Patient perspectives on research recruitment through cancer registries. Cancer Causes Control 16:1171-1175. (Pubitemid 46179501)
7. Beskow LM, Sandler RS, Weinberger M (2006) Research recruitment through US central cancer registries: balancing privacy and scientific issues. Am J Public Health 96:1920-1926. (Pubitemid 44655914)
8. Bobo JK, Shapiro JA, Brustrom J (2006) Efforts to locate low-income women for a study on mammography rescreening: implications for public health practice. J Community Health 31:249-261. (Pubitemid 43781351)
9. Carey LA, Perou CM, Livasy CA, et al. (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492-2502. (Pubitemid 43854964)
10. Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318-2324. (Pubitemid 26162426)
11. Cook DJ, Blythe D, Rischbieth A, et al. (2008) Enrollment of intensive care unit patients into clinical studies: a trinational survey of researchers' experiences, beliefs, and practices. Crit Care Med 36:2100-2105.
12. Curry L, Jackson J (2003) The science of including older ethnic and racial group participants in health-related research. Gerontologist 43:15-17. (Pubitemid 36222689)
13. Dunbar-Jacob J, Holmes JL, Sereika S, et al. (2004) Factors associated with attrition of African Americans during the recruitment phase of a clinical trial examining adherence among individuals with rheumatoid arthritis. Arthritis Rheum 51:422-428. (Pubitemid 38725142)
14. Fackenthal JD, Sveen L, Gao Q, et al. (2005) Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients. J Med Genet 42:276-281. (Pubitemid 40380311)
15. Fair AM, Wujcik D, Lin JM, et al. (2008) Timing is everything: methodologic issues locating and recruiting medically underserved women for abnormal mammography follow-up research. Contemp Clin Trials 29:537-546.
16. Fitzgibbon ML, Prewitt TE, Blackman LR, et al. (1998) Quantitative assessment of recruitment efforts for prevention trials in two diverse black populations. Prev Med 27:838-845. (Pubitemid 29010852)
17. Frank TS, Deffenbaugh AM, Reid JE, et al. (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480-1490. (Pubitemid 34260526)
18. Friebel TM, Beutler RA, Lee SM, et al. (2004) Active recruitment increased enrollment in a hereditary cancer registry. J Clin Epidemiol 57:1172-1176. (Pubitemid 39573024)
19. Gadegbeku CA, Stillman PK, Huffman MD, et al. (2008) Factors associated with enrollment of African Americans into a clinical trial: results from the African American study of kidney disease and hypertension. Contemp Clin Trials 29:837-842.
20. Gao Q, Adebamowo CA, Fackenthal J, et al. (2000a) Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer. Hum Genet 107:192-194.
21. Gao Q, Neuhausen S, Cummings S, et al. (1997) Recurrent germline BRCA1 mutations in extended African American families with early-onset breast cancer. Am J Hum Genet 60:1233-1236. (Pubitemid 27194108)
22. Gao Q, Tomlinson G, Das S, et al. (2000b) Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer. Hum Genet 107:186-191.
23. Haffty B, Silber A, Matloff E, et al. (2006) Racial Differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of Early Onset Breast Cancer patients: African American compared to White Women. J Med Genet 43:133-137 (Pubitemid 43259625)
24. Halbert CH, Brewster K, Collier A, et al. (2005) Recruiting African American women to participate in hereditary breast cancer research. J Clin Oncol 23:7967-7973.
25. Halbert CH, Kessler L, Stopfer JE, et al. (2006) Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breastovarian cancer. Genet Med 8:576-582. (Pubitemid 44402035)
26. Haughton LT, Kreuter M, Hall J, et al. (2005) Digital divide and stability of access in African American women visiting urban public health centers. J Health Care Poor Underserved 16:362-374. (Pubitemid 40935230)
27. Hughes C, Gomez-Caminero A, Benkendorf J, et al. (1997) Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 32: 51-62. (Pubitemid 27395979)
28. James AS, Hudson MA, Campbell MK (2003) Demographic and psychosocial correlates of physical activity among African Americans. Am J Health Behav 27:421-431. (Pubitemid 37123468)
29. John EM, Miron A, Gong G, et al. (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298:2869-2876.
30. Kanaan Y, Kpenu E, Utley K, et al. (2003) Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases. Hum Genet 113:452-460. (Pubitemid 37254250)
31. Kinney AY, Croyle RT, Dudley WN, et al. (2001) Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation. Prev Med 33:543-551. (Pubitemid 34101877)
32. Kolonel LN, Henderson BE, Hankin JH, et al. (2000) A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 151:346-357. (Pubitemid 30463612)
33. Lenfant C (1995) Enhancing minority participation in research. The NHLBI experience. Circulation 92:279-280.
34. Lerman C, Hughes C, Benkendorf JL, et al. (1999) Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev 8:361-367. (Pubitemid 29193891)
35. Linden HM, Reisch LM, Hart A, Jr., et al. (2007) Attitudes toward participation in breast cancer randomized clinical trials in the African American community: a focus group study. Cancer Nurs 30:261-269. (Pubitemid 47196600)
36. Malone KE, Daling JR, Doody DR, et al. (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66:8297-8308. (Pubitemid 44299201)
37. Marchbanks PA, McDonald JA, Wilson HG, et al. (2002) The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol 12:213-221. (Pubitemid 34414934)
38. Marcus AC, Kaplan CP, Crane LA, et al. (1998) Reducing loss-to-follow-up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow-up protocol and economic incentives. Med Care 36:397-410.
39. McGraw SA, McKinlay JB, Crawford SA, et al. (1992) Health survey methods with minority populations: some lessons from recent experience. Ethn Dis 2:273-287.
40. Mefford HC, Baumbach L, Panguluri RC, et al. (1999) Evidence for a BRCA1 founder mutation in families of West African ancestry. Am J Hum Genet 65:575-578. (Pubitemid 30463018)
41. Millon-Underwood S, Sanders E, Davis M (1993) Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans. Cancer Nurs 16:25-33. (Pubitemid 23084453)
42. Moorman PG, Newman B, Millikan RC, et al. (1999) Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol 9:188-195. (Pubitemid 29144459)
43. Nanda R, Schumm LP, Cummings S, et al. (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294: 1925-1933. (Pubitemid 41464694)
44. Newman B, Mu H, Butler LM, et al. (1998) Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 279:915-921. (Pubitemid 28136080)
45. Newman LA (2005) Breast cancer in African-American women. Oncologist 10:1-14.
46. Olopade OI, Fackenthal JD, Dunston G, et al. (2003) Breast cancer genetics in African Americans. Cancer 97:236-245. (Pubitemid 36033845)
47. Pal T, Permuth-Wey J, Holtje T, Sutphen R (2004) BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. Cancer Epidemiol Biomarkers Prev 13:1794-1799. (Pubitemid 39482958)
48. Pal T, Vadaparampil S, Betts J, et al. (2008) BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies. Genet Test 12:401-407.
49. Panguluri RC, Brody LC, Modali R, et al. (1999) BRCA1 mutations in African Americans. Hum Genet 105:28-31. (Pubitemid 29396960)
50. Pegoraro RJ, Moodley M, Rom L, et al. (2003) P53 codon 72 polymorphism and BRCA 1 and 2 mutations in ovarian epithelial malignancies in black South Africans. Int J Gynecol Cancer 13:444-449. (Pubitemid 38220662)
51. Penedo FJ, Molton I, Dahn JR, et al. (2006) A randomized clinical trial of group-based cognitive-behavioral stress management in localized prostate cancer: development of stress management skills improves quality of life and benefit finding. Ann Behav Med 31:261-270. (Pubitemid 43825352)
52. Permuth-Wey J, Vadaparampil S, Rumphs A, et al. (2010) Development of a culturally tailored genetic counseling booklet about hereditary breast and ovarian cancer for Black women. Am J Med Genet A 152A:836-845.
53. Psaty BM, Cheadle A, Koepsell TD, et al. (1994) Race- and ethnicity-specific characteristics of participants lost to follow-up in a telephone cohort. Am J Epidemiol 140:161-171. (Pubitemid 24205813)
54. Rimer BK, Conaway MR, Lyna PR, et al. (1996) Cancer screening practices among women in a community health center population. Am J Prev Med 12:351-357. (Pubitemid 26376176)
55. Royal C, Baffoe-Bonnie A, Kittles R, et al. (2000) Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Ann Epidemiol 10:S68-S77.
56. Satia JA, Galanko JA, Rimer BK (2005) Methods and strategies to recruit African Americans into cancer prevention surveillance studies. Cancer Epidemiol Biomarkers Prev 14:718-721. (Pubitemid 40489221)
57. Shen D, Wu Y, Subbarao M, et al. (2000) Mutation analysis of BRCA1 gene in African-American patients with breast cancer. J Natl Med Assoc 92:29-35.
58. Simon MS, Petrucelli N (2009) Hereditary breast and ovarian cancer syndrome: the impact of race on uptake of genetic counseling and testing. Methods Mol Biol 471:487-500.
59. Smith YR, Johnson AM, Newman LA, et al. (2007) Perceptions of clinical research participation among African American women. J Womens Health (Larchmt) 16:423-428. (Pubitemid 46668923)
60. Thompson HS, Valdimarsdottir HB, Duteau-Buck C, et al. (2002) Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiol Biomarkers Prev 11:1579-1585. (Pubitemid 36020010)
61. Vadaparampil S, Pal T. Updating and refining a study brochure for a cancer registry-based study of BRCA mutations among young African American breast cancer patients: lessons learned. J Community Genetics 1:63-71.
62. Vadaparampil S, Weber J, Betts J, Pal T (2007) Developing recruitment approaches, study materials, and study procedures for a cancer registry-based study of BRCA1/2 mutations among young African American breast cancer patients: lessons learned. Presented at the Amercian Society of Human Genetics 57th Annual Meeting, San Diego, California.
63. Vollmer WM, Svetkey LP, Appel LJ, et al. (1998) Recruitment and retention of minority participants in the DASH controlled feeding trial. DASH Collaborative Research Group. Dietary approaches to stop hypertension. Ethn Dis 8:198-208.
64. Watson JM, Torgerson DJ (2006) Increasing recruitment to randomised trials: a review of randomised controlled trials. BMC Med Res Methodol 6:34.
65. Yancey AK, Ortega AN, Kumanyika SK (2006) Effective recruitment and retention of minority research participants. Annu Rev Public Health 27:1-28.